宏量营养素补充对早产或小于胎龄儿后期生长影响的系统综述与荟萃分析
该系统综述与荟萃分析纳入42项随机或半随机对照试验共4352名婴儿,评估宏量营养素补充对早产或小于胎龄儿后期生长的影响。主要结局儿童期BMI无显著改变(MD -0.10 kg/m2,95%CI -0.37~0.16,p=0.45)。幼儿期补充组体重和身长增加,但儿童期脂肪量增加、青春期和成年期无显著差异。
要点
- 早期宏量营养素补充未改变儿童期BMI(MD -0.10 kg/m2,p=0.45)。
- 幼儿期补充组体重增加0.16 kg、身长增加0.44 cm,但临床意义有限。
- 儿童期补充组脂肪量较高(MD 0.79 kg),但青春期和成年期无显著差异。
核心结论
- 无证据表明早期宏量营养素补充改变早产或小于胎龄儿儿童期BMI。
- 补充虽增加幼儿期体重和身长,但效应不一致且不太可能具有临床意义。
- 有限数据提示补充增加儿童期脂肪量,但该效应未持续至后期。
研究设计与样本
- 系统综述与荟萃分析,检索OvidMedline、Embase、Cochrane CENTRAL等数据库至2020年1月30日。
- 主要结局为儿童期BMI,采用随机效应模型合并数据。
主要发现
- 儿童期BMI:7项试验1136名儿童,MD -0.10 kg/m2(95%CI -0.37~0.16,p=0.45)。
- 幼儿期体重:31项试验2924名幼儿,MD 0.16 kg(95%CI 0.01~0.30,p=0.03);身长/身高:30项试验2889名幼儿,MD 0.44 cm(95%CI 0.10~0.77,p=0.01)。
- 儿童期脂肪量:2项试验201名儿童,MD 0.79 kg(95%CI 0.19~1.38,p=0.01)。
- 青春期BMI、身高、脂肪量及成年期体重z评分、身高z评分组间均无显著差异。
- 亚组分析:幼儿期男童身长/身高增加(2项试验173名男童,MD 1.66 cm,95%CI 0.75~2.58,p=0.0003),女童无显著差异。
临床怎么用
- 对早产或小于胎龄儿进行早期宏量营养素补充时,应权衡幼儿期生长获益与儿童期脂肪量增加的潜在风险。
- 补充对长期BMI无显著影响,无需因担心远期肥胖而过度限制,但需关注儿童期体成分变化。
局限性
- 存在 considerable 无法解释的异质性。
- 证据质量低至极低。
- 随访率低或不均衡可能导致偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nutritional supplements may improve short-term growth of infants born small (preterm or small for gestational age), but there are few data on long-term effects and concerns that body composition may be adversely affected. Effects also may differ between girls and boys. Our systematic review and meta-analysis assessed the effects of macronutrient supplements for infants born small on later growth. METHODS AND FINDINGS: We searched OvidMedline, Embase, Cochrane CENTRAL, and Cochrane Database of Systematic Reviews from inception to January 30, 2020, and controlled-trials.com, clinicaltrials.gov, and anzctr.org.au on January 30, 2020. Randomised or quasirandomised trials were included if the intention was to increase macronutrient intake to improve growth or development of infants born small and growth was assessed after discharge. Primary outcome was body mass index (BMI) in childhood. Data were pooled using random-effect models. Outcomes were evaluated in toddlers (< 3 years), childhood (3 to 8 years), adolescence (9 to 18 years), and adulthood (>18 years). Forty randomised and 2 quasirandomised trials of variable methodological quality with 4,352 infants were included. Supplementation did not alter BMI in childhood (7 trials, 1,136 children; mean difference [MD] -0.10 kg/m2, [95% confidence interval (CI) -0.37 to 0.16], p = 0.45). In toddlers, supplementation increased weight (31 trials, 2,924 toddlers; MD 0.16 kg, [0.01 to 0.30], p = 0.03) and length/height (30 trials, 2,889 toddlers; MD 0.44 cm, [0.10 to 0.77], p = 0.01), but not head circumference (29 trials, 2,797 toddlers; MD 0.15 cm, [-0.03 to 0.33], p = 0.10). In childhood, there were no significant differences between groups in height (7 trials, 1,136 children; MD 0.22 cm, [-0.48 to 0.92], p = 0.54) or lean mass (3 trials, 354 children; MD -0.07 kg, [-0.98 to 0.85], p = 0.88), although supplemented children appeared to have higher fat mass (2 trials, 201 children; MD 0.79 kg, [0.19 to 1.38], p = 0.01). In adolescence, there were no significant differences between groups in BMI (2 trials, 216 adolescents; MD -0.48 kg/m2, [-2.05 to 1.08], p = 0.60), height (2 trials, 216 adolescents; MD -0.55 cm, [-2.95 to 1.86], p = 0.65), or fat mass (2 trials, 216 adolescents; MD -1.3 5 kg, [-5.76 to 3.06], p = 0.55). In adulthood, there also were no significant differences between groups in weight z-score (2 trials, 199 adults; MD -0.11, [-0.72 to 0.50], p = 0.73) and height z-score (2 trials, 199 adults; MD -0.07, [-0.36 to 0.22], p = 0.62). In subgroup analysis, supplementation was associated with increased length/height in toddler boys (2 trials, 173 boys; MD 1.66 cm, [0.75 to 2.58], p = 0.0003), but not girls (2 trials, 159 girls; MD 0.15 cm, [-0.71 to 1.01], p = 0.74). Limitations include considerable unexplained heterogeneity, low to very low quality of evidence, and possible bias due to low or unbalanced followup. CONCLUSIONS: In this systematic review and meta-analysis, we found no evidence that early macronutrient supplementation for infants born small altered BMI in childhood. Although supplements appeared to increase weight and length in toddlers, effects were inconsistent and unlikely to be clinically significant. Limited data suggested that supplementation increased fat mass in childhood, but these effects did not persist in later life. PROSPERO registration: CRD42019126918.
引用
- Lin L, Amissah E, Gamble GD, et al. Impact of macronutrient supplements on later growth of children born preterm or small for gestational age: A systematic review and meta-analysis of randomised and quasirandomised controlled trials. PLoS Med. 2020. PMID: 32453739. doi:10.1371/journal.pmed.1003122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。